Tuberous sclerosis in a 19-week fetus: Immunohistochemical and molecular study of hamartin and tuberin

Pediatric and Developmental Pathology

Volumn 5, Issue 5, 2002, Pages 448-464

  Wei, Jianjun ^a   Li, Peng ^a   Chiriboga, Luis ^a   Mizuguchi, Masashi ^b   Yee, Herman ^a   Miller, Douglas C ^a   Greco, M Alba ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Fetus; Hamartin; Immunohistochemistry; Loss of herozygosity; Tuberin; Tuberous sclerosis complex

Indexed keywords

HAMARTIN; TUBERIN;

ARTICLE; CASE REPORT; CELLULAR DISTRIBUTION; FETUS; GENE EXPRESSION; GENE MUTATION; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RHABDOMYOMA; TUBEROUS SCLEROSIS;

ADULT; ANIMALS; DNA; FEMALE; GENES, TUMOR SUPPRESSOR; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEINS; RABBITS; REPRESSOR PROTEINS; RHABDOMYOMA; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036759970     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10024-001-0210-3     Document Type: Article

References (53)

1. Hyman MH, Whittemore VH. National Institutes of Health Consensus Conference: Tuberous sclerosis complex. Arch Neurol 2000;157:662-665.
2. Al-Saleem T, Wessner LL, Scheithauer BW, et al. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer 1998;83:2208-2216.
3. Verhoef S, van Diemen-Steenvoorde R, Akkersdijk WL, et al. Malignant pancreatic tumor within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr 1999;158:284-287.
4. Fukuda T, Kobayashi T, Momose S, Yasui H, Hino O. Distribution of TSC1 protein detected by immunohistochemistry in various normal rat tissues and the renal carcinomas of Eker rat: Detection of limited colocalization with TSC1 and TSC2 gene products in vivo. Lab Invest 2000;80:1347-1359.
5. Van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997;277:805-808.
6. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305-1315.
7. Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2 and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64:1305-1315.
8. Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001;68:64-80.
9. Green AJ, Johnson PH, Yates JR. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994;3:1833-1834.
10. Sepp T, Yates JR, Green AJ. Loss of heterozygosity in tuberous sclerosis hamartomas. J Med Genet 1996;33:962-964.
11. Carbonara C, Longa L, Grosso E, et al. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 1996;15:18-25.
12. Henske EP, Wessner LL, Golden J, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol 1997;151: 1639-1647.
13. Au KS, Hebert AA, Roach ES, Northrup H. Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am J Hum Genet 1999;65:1790-1795.
14. Pasumarthi KB, Nakajima H, Nakajima HO, Jing S, Field LJ. Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 2000;86:1069-1077.
15. Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000;97:6085-6090.
16. Wienecke R, Maize JC Jr, Reed JA, de Gunzburg J, Yeung RS, DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 1997;150:43-50.
17. Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis 2 gene product functions as a rab5a GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 1997;272:6097-6100.
18. Altschuler DL, Ribeiro Neto F. Mitogenic and oncogenic properties of the small G protein Raplb. Proc Natl Acad Sci USA 1998;95:7475-7479.
19. York RD, Yao H, Dillon T, Ellig CL, et al. Rapl mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998;392:622-626.
20. Gorvel JP, Charvrier P, Zerial M, Gruenberg J. Rab5 controls early endosome fusion in vitro. Cell 1991;64:915-925.
21. Soucek T, Holzl G, Bernaschek G, Hengstschlager M. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 1998;16:2197-2204.
22. Crino PB, Henske EP. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999; 53:1384-1390.
23. Rennebeck G, Kleymenova EVT, Anderson R, Yeung RS, Artzt K, Walker CL. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA 1998;95:15629-15634.
24. Lamb RF, Roy C, Diefenbach TJ, et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2000;2:281-287.
25. Park S-H, Pepkowitz SH, Kerfoot C, et al. Tuberous sclerosis in a 20-week gestation fetus: Immunohistochemical study. Acta Neuropathol 1997;94:180-186.
26. Brackley KJ, Farndon PA, Weaver JB, Dow DJ, Chapman S, Kilby MD. Prenatal diagnosis of tuberous sclerosis with intracerebral signs at 14 weeks gestation. Prenat Diagn 1999;19:575-579.
27. Bordarier C, Lellouch-Tubiana A, Robain O. Cardiac rhabdomyoma and tuberous sclerosis in three fetuses: A neuropathological study. Acta Neuropathol 1994;16:467-471.
28. Menchine M, Emelin JK, Mischel PS, et al. Tissue and cell-type specific expression of the tuberous sclerosis gene, TSC2, in human tissues. Mod Pathol 1996;9:1071-1080.
29. Kerfoot C, Wienecke R, Menchine M, et al. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathol 1996;6:367-375.
30. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol 1997;94:525-531.
31. Plank TL, Logginidou H, Klein-Szanto A, Henske EP. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 1999;12:539-545.
32. Gutmann DH, Zhang Y, Hasbani MJ, et al. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues. Acta Neuropathol 2000;99:223-230.
33. Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV. Hamartin and tuberin expression in human tissues. Mod Pathol 2001;14:202-210.
34. Mizuguchi M, Ikeda K, Takashima S. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol 2000;99: 503-510.
35. Mizuguchi M, Kato M, Yamanouchi H, Ikeda K, Takashima S. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol 1996;40: 941-944.
36. Parry L, Maynard JH, Patel A, et al. Molecular analysis of the TSC1 and TSC2 tumor suppressor genes in sporadic glial and glioneuronal tumors. Hum Genet 2000;107:350356.
37. Soong R, Iacopetta BJ. A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Mod Pathol 1997;10:252-258.
38. Wei J, Hodes ME, Wang Y, Feng Y, Ghetti B, Dlouhy SR. Direct cDNA selection with DNA microdissected from mouse chromosome 16: Isolation of novel clones and construction of a partial transcription map of the C3-C4 region. Genome Res 1996;6:678-687.
39. Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AM, Halley DJ, van der Sluijs P. Characterization of the cytosolic tuberin-hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem 1999;274: 35647-35652.
40. Murthy V, Haddad LA, Smith N, et al. Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney. Am J Physiol Renal Physiol 2000; 278:F737-F746.
41. Fukuda T, Kobayashi T, Yasui H, Tsutsumi M, Konishi Y, Hino O. Distribution of Tsc2 protein in various normal rat tissues and renal tumors of Tsc2 mutant (Eker) rat detected by immunohistochemistry. Virchows Arch 1999; 434:341-350.
42. Jozwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000; 15:652-659.
43. Potter CJ, Huang H, Xu T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 2001;105: 357-368.
44. Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 2001;105: 345-355.
45. Astrinidis A, Khare L, Carsillo T, et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet 2000; 37:55-57.
46. Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: Chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am J Hum Genet 1998;62:810-815.
47. Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998;58:4766-4770.
48. Tsuchiya H, Orimoto K, Kobayashi K, Hino O. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res 1996;56:429-433.
49. Henry KW, Yuan X, Koszewski NJ, Onda H, Kwiatkowski DJ, Noonan DJ. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 1998;273:20535-20539.
50. Wolf DC, Goldsworthy TL, Donner EM, Harden R, Fitzpatrick B, Everitt JI. Estrogen treatment enhances hereditary renal tumor development in Eker rats. Carcinogenesis 1998;19:2043-2047.
51. Melchior F, Paschal B, Evans J, Gerace L. Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol 1993;123:1649-1659.
52. Zhang B, Berger J, Zhou G, et al. Insulin- and mitogenactivated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor. J Biol Chem 1996;271:31771-31774.
53. Soucek T, Yeung RS, Hengstschlager M. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc Natl Acad Sci USA 1998;95:15653-15658.